Latest News

Three major AI and cybersecurity names just sold off after earnings, and the next move could decide whether the bull run continues.

Google just raised $80 billion, and Meta's setup looks better than ever, but one AI infrastructure name may be the biggest opportunity of them all.

The hot streak in the chip sector continued.

Software stocks are finally roaring back to life, and the next move investors make could define the rest of 2026.

Despite solid fundamentals, the credit card company's shares have fallen double digits in 2026.

The chip designer's business is firing on all cylinders as the AI market expands.

Orion (OESX) Q3 2026 Earnings Call Transcript

Orion (OESX) Q4 2026 Earnings Transcript

The robotic-surgery leader has lost nearly a third of its value since January. Here's what's weighing on the stock.

PVH (PVH) Q1 2026 Earnings Transcript

Ciena just served up a beat-and-raise quarter. So why is the stock falling?

CMCO Q4 2026 Earnings Transcript

HPE's Q2 revenue surged 40% to $10.7 billion with a record $5.9 billion AI backlog, while Super Micro pivots to edge computing to defend its market position.

NuScale Power could be nearing its first major deal. Should investors pounce before it does?

SpaceX may be a remarkable company, but its IPO could prove far less rewarding for ordinary investors.

Adicet Bio (NASDAQ:ACET) outlined its near-term clinical priorities and upcoming data catalysts during a fireside chat at the Jefferies Healthcare Conference in New York, with President and CEO Chen Schor emphasizing the company’s focus on off-the-shelf gamma delta 1 T-cell therapies for autoimmune

An above-average boost is looking pretty likely.

Bull Cases, Bear Cases, and a CFP's Verdict

Blackstone's flagship private credit fund again saw high redemption requests in the second quarter.

Generac's strategic pivot into the AI data center market is solidified by a new global supply agreement that positions it as a key player in grid resilience.

Could this $271 billion memory giant reach $500 billion soon?

Profits are soaring, for now. That does not guarantee they will in the future.

Explore how these two healthcare ETFs differ in diversification, sector focus, and portfolio concentration—key factors shaping their long-term investor appeal.

Palantir is tying up with Google in an alliance of AI heavyweights.

It will be difficult for passive investors to overlook this hassle-free opportunity.